GNLX

Genelux Corp. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website genelux.com
Employees(FY) 22
ISIN US36870H1032

Performance

-9.2%

1W

+3.69%

1M

-53.5%

3M

-72.18%

6M

-73.95%

YTD

-85.22%

1Y

Profile

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1, an animal health product candidate. It has a licensing agreement with ELIAS Animal Health, LLC. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California.

Advanced Technical Analysis

Technical Analysis of GNLX 2024-05-10

Overview:

In analyzing the technical indicators for GNLX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.

Trend Analysis:

Moving Averages (MA): The 5-day Moving Average (MA) has been consistently above the S...

See more ...

Recent News & Updates

2024-05-09 11:53
GNLX Stock Earnings: Genelux Misses EPS for Q1 2024(Investorplace)
2024-05-09 04:25
Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates(Globenewswire)
2024-04-25 21:35
Down -48.37% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround(Zacks)
2024-04-22 21:35
Down -45.44% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround(Zacks)
2024-04-04 21:35
After Plunging -26.21% in 4 Weeks, Here's Why the Trend Might Reverse for Genelux Corporation (GNLX)(Zacks)
2024-04-04 00:00
All You Need to Know About Genelux Corporation (GNLX) Rating Upgrade to Buy(Zacks)
2024-04-01 19:52
GNLX Stock Earnings: Genelux Misses EPS for Q4 2023(Investorplace)
2024-03-31 19:00
Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update(Globenewswire)
2023-12-15 02:01
Insider Sell Alert: Director James Tyree Offloads 9,000 Shares of Genelux Corp (GNLX)(Yahoo Finance)
2023-11-26 18:00
Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer(Globenewswire)
2023-11-14 04:50
Genelux Corporation Reports Third Quarter 2023 Financial Results and Provides General Business Updates(Globenewswire)
2023-10-20 01:22
12 Best Performing Biotech Stocks in 2023(Yahoo Finance)
2023-10-10 21:00
Young Adults and Pancreatic Cancer: What the 80% Rise in Diagnoses Means for Future Treatment(Prnewswire)
2023-09-19 03:01
Director John Thomas Sells 6667 Shares of Genelux Corp (GNLX)(Yahoo Finance)
2023-09-15 03:03
Director John Smither Sells 900 Shares of Genelux Corp (GNLX)(Yahoo Finance)
2023-09-14 01:21
10% Owner Aladar Szalay Sells 52,616 Shares of Genelux Corp (GNLX)(Yahoo Finance)
2023-09-13 19:00
Genelux Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(Yahoo Finance)
2023-09-07 04:01
Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference(Yahoo Finance)
2023-08-27 19:00
Genelux Corporation Announces New Chief Financial Officer(Yahoo Finance)
2023-08-13 19:00
Genelux Corporation Reports Second Quarter 2023 Financial Results and Provides General Business Updates(Yahoo Finance)
2023-08-02 04:00
Genelux Corporation to Participate in Fireside Chat at BTIGs Virtual Biotechnology Conference 2023(Yahoo Finance)
2023-08-01 13:08
10 Recent IPOs in 2023 to Consider(Yahoo Finance)
2023-07-27 22:54
Why Shares of Genelux Climbed This Week(Yahoo Finance)
2023-07-20 04:45
Genelux Corporation Strengthens Senior Management and Clinical Team with Promotions and New Hires(Yahoo Finance)
2023-07-09 19:00
Genelux Corporation Announces Publication of Phase I Trial Results of Intrapleural Administration of Olvi-Vec in Patients with Malignant Pleural Effusion from Mesothelioma, Lung or Breast Cancers in Frontiers in Immunology(Yahoo Finance)
2023-06-28 19:00
Genelux Corporation and TVAX Biomedical, Inc. announce the issuance of a United States patent covering the combination of an adoptive T cell therapy/oncolytic viral cancer treatment that is exclusively licensed to V2ACT Therapeutics, LLC(Yahoo Finance)
2023-06-21 19:00
Genelux Corporation Set to Join the Russell 3000® and Russell 2000® Indexes Effective June 26, 2023(Yahoo Finance)
2023-06-11 19:00
Genelux Corporation Announces $18 Million Private Placement(Yahoo Finance)
2023-06-01 05:19
Why Shares of Genelux Corporation Jumped This Week(Yahoo Finance)
2023-05-25 04:01
Genelux Corporation Announces Publication of Positive Topline Data from Phase 2 VIRO-15 Trial Evaluating Olvimulogene Nanivacirepvec (Olvi-Vec) in Platinum-Resistant or Refractory Ovarian Cancer in the Journal of the American Medical Association (JAMA) Onc(Yahoo Finance)

Page 1 of 2

previousnext